Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Czaplinski JT"'
Autor:
Serrano C; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, 20 Shattuck Street, Thorn 528, Boston, MA, USA. cserrano@vhio.net.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. cserrano@vhio.net.; Sarcoma Translational Research Laboratory, Vall d'Hebron Institute of Oncology; Department of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain. cserrano@vhio.net., Mariño-Enríquez A; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, 20 Shattuck Street, Thorn 528, Boston, MA, USA., Tao DL; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, 20 Shattuck Street, Thorn 528, Boston, MA, USA., Ketzer J; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany., Eilers G; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, 20 Shattuck Street, Thorn 528, Boston, MA, USA., Zhu M; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, 20 Shattuck Street, Thorn 528, Boston, MA, USA., Yu C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, 7 Cambridge Center, Cambridge, MA, USA.; Daiichi Sankyo Inc., Basking Ridge, NJ, USA., Mannan AM; Broad Institute of MIT and Harvard, 7 Cambridge Center, Cambridge, MA, USA., Rubin BP; Department of Molecular Genetics, Lerner Research Institute and Cleveland Clinic, 9500, Euclid Ave, Cleveland, OH, USA., Demetri GD; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Ludwig Center for Cancer Research at Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA., Raut CP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Division of Surgical Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, 75 Francis Street, Boston, MA, USA., Presnell A; Portland VA Medical Center and OHSU Knight Cancer Institute, Portland, Oregon, USA., McKinley A; Portland VA Medical Center and OHSU Knight Cancer Institute, Portland, Oregon, USA., Heinrich MC; Portland VA Medical Center and OHSU Knight Cancer Institute, Portland, Oregon, USA., Czaplinski JT; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Sicinska E; Department of Oncologic Pathology, Dana Farber Cancer Institute, Boston, MA, USA., Bauer S; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany., George S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Fletcher JA; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, 20 Shattuck Street, Thorn 528, Boston, MA, USA. jfletcher@partners.org.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. jfletcher@partners.org.
Publikováno v:
British journal of cancer [Br J Cancer] 2019 Jul; Vol. 121 (3), pp. 281.
Autor:
Serrano C; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, 20 Shattuck Street, Thorn 528, Boston, MA, USA. cserrano@vhio.net.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. cserrano@vhio.net.; Sarcoma Translational Research Laboratory, Vall d'Hebron Institute of Oncology; Department of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain. cserrano@vhio.net., Mariño-Enríquez A; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, 20 Shattuck Street, Thorn 528, Boston, MA, USA., Tao DL; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, 20 Shattuck Street, Thorn 528, Boston, MA, USA., Ketzer J; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany., Eilers G; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, 20 Shattuck Street, Thorn 528, Boston, MA, USA., Zhu M; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, 20 Shattuck Street, Thorn 528, Boston, MA, USA., Yu C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, 7 Cambridge Center, Cambridge, MA, USA.; Daiichi Sankyo Inc., Basking Ridge, NJ, USA., Mannan AM; Broad Institute of MIT and Harvard, 7 Cambridge Center, Cambridge, MA, USA., Rubin BP; Department of Molecular Genetics, Lerner Research Institute and Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH, USA., Demetri GD; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Ludwig Center for Cancer Research at Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA., Raut CP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Division of Surgical Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, 75 Francis Street, Boston, MA, USA., Presnell A; Portland VA Medical Center and OHSU Knight Cancer Institute, Portland, Oregon, USA., McKinley A; Portland VA Medical Center and OHSU Knight Cancer Institute, Portland, Oregon, USA., Heinrich MC; Portland VA Medical Center and OHSU Knight Cancer Institute, Portland, Oregon, USA., Czaplinski JT; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Sicinska E; Department of Oncologic Pathology, Dana Farber Cancer Institute, Boston, MA, USA., Bauer S; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany., George S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Fletcher JA; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, 20 Shattuck Street, Thorn 528, Boston, MA, USA. jfletcher@partners.org.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. jfletcher@partners.org.
Publikováno v:
British journal of cancer [Br J Cancer] 2019 Mar; Vol. 120 (6), pp. 612-620. Date of Electronic Publication: 2019 Feb 22.
Autor:
Nakayama R; Ludwig Center at Dana-Farber/Harvard and Center for Sarcoma and Bone Oncology, Department of Medical Oncology, Harvard Medical School, Boston, MA, USA.; Department of Orthopaedic Surgery, School of Medicine, Keio University, Tokyo, Japan., Zhang YX; Ludwig Center at Dana-Farber/Harvard and Center for Sarcoma and Bone Oncology, Department of Medical Oncology, Harvard Medical School, Boston, MA, USA., Czaplinski JT; Department of Medical Oncology and Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Anatone AJ; Department of Medical Oncology and Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Sicinska ET; Department of Medical Oncology and Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Fletcher JA; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Demetri GD; Ludwig Center at Dana-Farber/Harvard and Center for Sarcoma and Bone Oncology, Department of Medical Oncology, Harvard Medical School, Boston, MA, USA., Wagner AJ; Ludwig Center at Dana-Farber/Harvard and Center for Sarcoma and Bone Oncology, Department of Medical Oncology, Harvard Medical School, Boston, MA, USA.
Publikováno v:
Oncotarget [Oncotarget] 2016 Mar 29; Vol. 7 (13), pp. 16581-92.
Autor:
Eilers G; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Czaplinski JT; Center for Molecular Oncologic Pathology, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Mayeda M; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Bahri N; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Tao D; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Zhu M; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Hornick JL; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Lindeman NI; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Sicinska E; Center for Molecular Oncologic Pathology, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Wagner AJ; Center for Sarcoma and Bone Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Fletcher JA; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. admarino@partners.org jfletcher@partners.org., Mariño-Enriquez A; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. admarino@partners.org jfletcher@partners.org.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2015 Jun; Vol. 14 (6), pp. 1346-53. Date of Electronic Publication: 2015 Apr 07.
Autor:
Zhang YX; Ludwig Center at Dana-Farber/Harvard, Harvard Medical School, Boston, Massachusetts. Department of Medical Oncology, Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Sicinska E; Ludwig Center at Dana-Farber/Harvard, Harvard Medical School, Boston, Massachusetts. Department of Medical Oncology, Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts., Czaplinski JT; Ludwig Center at Dana-Farber/Harvard, Harvard Medical School, Boston, Massachusetts. Department of Medical Oncology, Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts., Remillard SP; Ludwig Center at Dana-Farber/Harvard, Harvard Medical School, Boston, Massachusetts. Department of Medical Oncology, Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Moss S; Ludwig Center at Dana-Farber/Harvard, Harvard Medical School, Boston, Massachusetts. Department of Medical Oncology, Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts., Wang Y; Department of Radiology, Johns Hopkins School of Medicine, Baltimore, Maryland., Brain C; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts., Loo A; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts., Snyder EL; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts., Demetri GD; Ludwig Center at Dana-Farber/Harvard, Harvard Medical School, Boston, Massachusetts. Department of Medical Oncology, Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Kim S; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts., Kung AL; Department of Pediatrics, Columbia University Medical Center, New York, New York., Wagner AJ; Ludwig Center at Dana-Farber/Harvard, Harvard Medical School, Boston, Massachusetts. Department of Medical Oncology, Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Andrew_Wagner@dfci.harvard.edu.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2014 Sep; Vol. 13 (9), pp. 2184-93. Date of Electronic Publication: 2014 Jul 15.
Autor:
Mariño-Enríquez A; 1] Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA [2] Departamento de Anatomía Patológica, Hospital Universitario La Paz, Fundación para la Investigación Biomédica FIBHULP, Universidad Autónoma de Madrid, IdiPAZ, Madrid, Spain., Ou WB; 1] Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA [2] Zhejiang Provincial Key Laboratory of Applied Enzymology, Yangtze Delta Region Institute of Tsinghua University, Jiaxing, Zhejiang, China., Cowley G; RNAi Platform, Broad Institute of Harvard and MIT, Cambridge, MA, USA., Luo B; RNAi Platform, Broad Institute of Harvard and MIT, Cambridge, MA, USA., Jonker AH; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Mayeda M; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Okamoto M; RNAi Platform, Broad Institute of Harvard and MIT, Cambridge, MA, USA., Eilers G; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Czaplinski JT; Center for Molecular Oncologic Pathology, Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Sicinska E; Center for Molecular Oncologic Pathology, Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Wang Y; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Taguchi T; Department of Human Health and Medical Science, Graduate School of Kuroshio Science, Kochi University, Nankoku, Kochi, Japan., Demetri GD; Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Root DE; RNAi Platform, Broad Institute of Harvard and MIT, Cambridge, MA, USA., Fletcher JA; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Publikováno v:
Oncogene [Oncogene] 2014 Apr 03; Vol. 33 (14), pp. 1872-6. Date of Electronic Publication: 2013 Apr 15.